Showing results (81-90 of 422) with videos related to
Sort By:
Pageof 43
Journal of Clinical Immunology|November 27, 2001
Mechanisms of cell-mediated myocytotoxicity in the peripheral blood of patients with inflammatory myopathiesI Bank, A F Miranda, L ChessSeminars in Thrombosis and Hemostasis|October 8, 1998
Factor V:Q506 mutation-resistance to activated protein C (APC): clinical implications with respect to family screeningS Middeldorp, J van der MeerIntensive Care Medicine|January 26, 2002
Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjectsE de Jonge, M Levi, H R Büller, et al.Journal of Thrombosis and Haemostasis : JTH|July 26, 2011
How to prevent, treat, and overcome current clinical challenges of VTEJ Van Es, E S Eerenberg, P W Kamphuisen, et al.Archives of Internal Medicine|March 13, 1999
Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolismP M Kuijer, B A Hutten, M H Prins, et al.Thrombosis and Haemostasis|May 9, 2001
Acute pulmonary embolism: impact of selection bias in prospective diagnostic studies. ANTELOPE Study Group. Advances in New Technologies Evaluating the Localization of Pulmonary EmbolismI J Hartmann, M H Prins, H R Büller, et al.Progress in Clinical and Biological Research|January 1, 1985
Validity of the endotoxin assay in post surgical patientsH R Büller, J W ten Cate, A Sturk, et al.Thrombosis and Haemostasis|January 23, 1992
Deep vein thrombosis in obstetric patients: diagnosis and risk factorsK de Boer, H R Büller, J W ten Cate, et al.Nederlands Tijdschrift Voor Geneeskunde|May 29, 2003
[New anticoagulants]M Levi, R J G Peters, J J Piek, et al.Haemostasis|January 1, 1995
Noninvasive objective tests for the diagnosis of clinically suspected deep-vein thrombosisA Cogo, A W Lensing, P Wells, et al.Pageof 43